thyssenkrupp nucera (NCH2) Q4 2025 earnings summary

Executive summary

• Fiscal year 2024-2025 marked by diligent project execution, technology innovation, and focused investments in green hydrogen and chlor-alkali segments.

• Maintained a robust financial base and demonstrated resilience through strict cost discipline in a volatile market.

• Advanced as preferred technology provider for green hydrogen projects totaling over 3 GW capacity and awarded several new chlor-alkali contracts.

• Service business expanded, with significant progress on major projects like NEOM and Stegra.

• Demonstrated strong ESG performance, high compliance and safety, and progress on sustainability targets.

Financial highlights

• Group sales reached EUR 845 million, slightly below guidance, down 2% year-over-year.

• Returned to positive EBIT territory with EUR 2 million, up EUR 17 million year-over-year.

• Net income was EUR 5 million, EPS at EUR +0.04, and free cash flow improved to EUR 11 million.

• Gross margin increased to 13% from 11% prior year, driven by improved project mix and cost discipline.

• Order intake declined 45% year-over-year to EUR 348 million, mainly due to delayed green hydrogen market ramp-up and project postponements.

Outlook and guidance

• Order intake for 2025-2026 expected between EUR 350 million and EUR 900 million, highly dependent on timing of large projects.

• Group sales forecasted at EUR 500 million–EUR 600 million; EBIT expected between EUR -30 million and EUR 0 million.

• Green hydrogen sales anticipated at EUR 150 million–EUR 220 million; chlor-alkali sales at EUR 320 million–EUR 400 million.

• Focus remains on disciplined execution, cost control, and innovation amid market volatility.